Comparison of Esketamine-Propofol & Fentanyl-Propofol

Status Recruiting

Clinical Trial Summary

Propofol is widely used as an induction agent during general anesthesia. The prevalent induction dose may be associated with unacceptable cardiovascular instability, especially in elderly patients.The combination of ketamine and propofol has been shown to balance the cardiodepressant effects. Esketamine is dextrorotatory structure of ketamine but with stronger analgesic effects and fewer adverse events.However, there have been no previous published reports on the use of esketamine combined with propofol during induction. The main aim of this study was to investigate the haemodynamic effects of esketamine with propofol for the elderly during induction with LMA( laryngeal mask airway) insertion.

Clinical Trial Description

Propofol is widely used as an induction agent during general anesthesia. The prevalent induction dose may be associated with unacceptable cardiovascular instability, especially in elderly patients. 1.7(0.6) mg.kg-1 adjusted dosed propofol demonstrated by a large multicenter cohort is suitable to advanced patients over aged 65. Ketamine increases heart rate and arterial blood pressure by its activation of the sympathetic nervous system. When it is used with propofol for induction of general anesthesia, the cardiostimulating effects of ketamine balance the cardiodepressant effects of propofol. Esketamine is dextrorotatory structure of ketamine but with stronger analgesic effects and fewer adverse events. A previous study has shown that the use of ketamine before induction with propofol preserves haemodynamic stability during LMA insertion. However, there have been no previous published reports on the use of esketamine combined with propofol in elderly patients for induction. The main aim of this study was to investigate the haemodynamic effects of esketamine with propofol during induction with LMA insertion. The secondary aim was to investigate whether the administration of esketamine in induction would delay the emergence of anesthesia. ;

Study Design

Related Conditions & MeSH terms

Hemodynamics

Clinical Trial Details

NCT number	NCT05752409
Study type	Interventional
Source	Eye & ENT Hospital of Fudan University
Contact	Fang Tan, Phd
Phone	8613611716000
Email	tanfang@eentanesthesia.com
Status	Recruiting
Phase	N/A
Start date	October 8, 2021
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04585568` - Validation of Ballistocardiographic Biosensors and Other Hemodynamic Measures for Healthy Subjects
Not yet recruiting	`NCT02202239` - Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients	Phase 4
Terminated	`NCT01116973` - Reliability of Central Venous Pressure Measurements	N/A
Completed	`NCT04595591` - Observation of Propofol Titration at Different Speeds	N/A
Not yet recruiting	`NCT03729817` - REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis	N/A
Completed	`NCT01974557` - The Effect of Age on the Hemodynamic Response During Rest and Exercise in Healthy Humans	N/A
Completed	`NCT00620386` - Endotracheal Intubation Using Bonfils Fibrescope Without Neuromuscular Blockade	Phase 2/Phase 3
Recruiting	`NCT06082856` - Evaluation of the Hemodynamic Effect of Dexmedetomidine in Scheduled Outpatient Surgery	N/A
Recruiting	`NCT04665817` - Diagnostic Accuracy of CCTA-derived Versus AngiogRaphy-dErived QuantitativE Flow Ratio (CAREER) Study
Recruiting	`NCT03684291` - Hemodynamic Effects of Ventilation Modes
Recruiting	`NCT04291196` - Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT	N/A
Terminated	`NCT02495662` - The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation	Phase 2
Completed	`NCT01559285` - Effects of Epidurally Administered Ropivacaine Concentration on the Hemodynamic Parameters	Phase 4
Completed	`NCT04131699` - Electrical Velocimetry (ICON Cardiometry ) Assessment of Hemodynamic Changes During Pediatric Thoracoscopic Surgery
Completed	`NCT05145114` - Hemodynamic Repercussions in Different Therapeutic Positions in Premature Newborn	N/A
Completed	`NCT04419662` - Evaluation of Patients After Cardiac Surgery: Novel Ultrasound Parameters for Quantification of Renal Perfusion & Analysis of Phenylephrines' Effect on Invasive Haemodynamics and Echocardiographic Measures	Phase 4
Completed	`NCT02902068` - Hemodynamic Monitoring in Women Throughout Cesarean Sections
Recruiting	`NCT00730899` - Association Study of Gene Polymorphisms With Cardiac Performance	N/A
Recruiting	`NCT03855579` - Levosimendan Versus Milrinone in Off Pump CABG Surgery	Phase 4
Recruiting	`NCT04819802` - MIcrovascular Dysfunction in CRitically Ill cOVID-19 Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Esketamine-Propofol and Fentanyl-Propofol

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms